Veracyte Return on Tangible Equity 2012-2025 | VCYT
Current and historical return on tangible equity values for Veracyte (VCYT) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Veracyte Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $0.03B | $0.34B | 10.62% |
| 2024-12-31 | $0.02B | $0.33B | 8.36% |
| 2024-09-30 | $-0.01B | $0.31B | -3.35% |
| 2024-06-30 | $-0.05B | $0.27B | -21.47% |
| 2024-03-31 | $-0.07B | $0.25B | -28.42% |
| 2023-12-31 | $-0.07B | $0.25B | -32.17% |
| 2023-09-30 | $-0.05B | $0.24B | -22.96% |
| 2023-06-30 | $-0.03B | $0.22B | -13.99% |
| 2023-03-31 | $-0.03B | $0.21B | -15.50% |
| 2022-12-31 | $-0.04B | $0.20B | -19.12% |
| 2022-09-30 | $-0.04B | $0.20B | -23.28% |
| 2022-06-30 | $-0.05B | $0.19B | -26.34% |
| 2022-03-31 | $-0.05B | $0.19B | -21.38% |
| 2021-12-31 | $-0.08B | $0.19B | -28.87% |
| 2021-09-30 | $-0.07B | $0.18B | -23.82% |
| 2021-06-30 | $-0.06B | $0.34B | -17.97% |
| 2021-03-31 | $-0.07B | $0.34B | -21.33% |
| 2020-12-31 | $-0.04B | $0.36B | -13.42% |
| 2020-09-30 | $-0.03B | $0.36B | -15.89% |
| 2020-06-30 | $-0.03B | $0.16B | -17.32% |
| 2020-03-31 | $-0.02B | $0.16B | -11.47% |
| 2019-12-31 | $-0.01B | $0.17B | -7.12% |
| 2019-09-30 | $-0.01B | $0.22B | -5.62% |
| 2019-06-30 | $-0.01B | $0.21B | -10.58% |
| 2019-03-31 | $-0.02B | $0.07B | -27.78% |
| 2018-12-31 | $-0.02B | $0.07B | -54.66% |
| 2018-09-30 | $-0.03B | $0.07B | -92.31% |
| 2018-06-30 | $-0.03B | $0.01B | -151.90% |
| 2018-03-31 | $-0.03B | $0.02B | -124.00% |
| 2017-12-31 | $-0.03B | $0.02B | -98.36% |
| 2017-09-30 | $-0.03B | $0.03B | -72.73% |
| 2017-06-30 | $-0.03B | $0.03B | -76.92% |
| 2017-03-31 | $-0.03B | $0.04B | -100.87% |
| 2016-12-31 | $-0.03B | $0.04B | -119.23% |
| 2016-09-30 | $-0.04B | $0.02B | -147.37% |
| 2016-06-30 | $-0.04B | $0.02B | -125.62% |
| 2016-03-31 | $-0.04B | $0.03B | -95.36% |
| 2015-12-31 | $-0.03B | $0.04B | -95.77% |
| 2015-09-30 | $-0.03B | $0.04B | -103.82% |
| 2015-06-30 | $-0.03B | $0.05B | -109.09% |
| 2015-03-31 | $-0.03B | $0.02B | -105.08% |
| 2014-12-31 | $-0.03B | $0.02B | -80.00% |
| 2014-09-30 | $-0.03B | $0.03B | -61.54% |
| 2014-06-30 | $-0.03B | $0.05B | -67.97% |
| 2014-03-31 | $-0.03B | $0.05B | -86.21% |
| 2013-12-31 | $-0.03B | $0.06B | -151.52% |
| 2013-06-30 | $-0.02B | $0.01B | -900.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $1.851B | $0.446B |
| Veracyte, Inc. is a diagnostics company. It is focused on discovering, developing and commercializing molecular cytology solutions. The Company provides Afirma Thyroid FNA Analysis, which helps physicians in reducing unnecessary diagnostic surgeries for patients with thyroid nodules. Veracyte is also developing Afirma Malignant GEC test. It serves endocrinologists, radiologists, and head and neck specialists. Veracyte, Inc. is headquartered in South San Francisco, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $174.795B | 21.15 |
| Intuitive Surgical (ISRG) | United States | $173.187B | 71.79 |
| Edwards Lifesciences (EW) | United States | $46.535B | 30.87 |
| Alcon (ALC) | Switzerland | $43.341B | 29.29 |
| IDEXX Laboratories (IDXX) | United States | $43.069B | 49.50 |
| DexCom (DXCM) | United States | $31.090B | 46.64 |
| IQVIA Holdings (IQV) | United States | $31.017B | 17.53 |
| Mettler-Toledo (MTD) | United States | $24.882B | 29.27 |
| STERIS (STE) | Ireland | $22.317B | 24.58 |
| Waters (WAT) | United States | $17.276B | 24.38 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.058B | 0.00 |
| Hologic (HOLX) | United States | $14.966B | 16.18 |
| Sysmex ADR (SSMXY) | Japan | $10.399B | 29.50 |
| Penumbra (PEN) | United States | $9.477B | 69.23 |
| Masimo (MASI) | United States | $8.347B | 30.79 |
| Globus Medical (GMED) | United States | $7.126B | 16.98 |
| Teleflex (TFX) | United States | $5.121B | 8.27 |
| Glaukos (GKOS) | United States | $4.923B | 0.00 |
| TransMedics (TMDX) | United States | $4.110B | 62.46 |
| Integer Holdings (ITGR) | United States | $3.732B | 18.62 |
| PROCEPT BioRobotics (PRCT) | United States | $2.764B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.243B | 13.35 |
| Alphatec Holdings (ATEC) | United States | $2.013B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.982B | 22.73 |
| Elekta AB (EKTAY) | Sweden | $1.833B | 16.48 |
| Artivion (AORT) | United States | $1.320B | 123.68 |
| Tandem Diabetes Care (TNDM) | United States | $1.026B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.992B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.957B | 5.50 |
| OPKO Health (OPK) | United States | $0.944B | 0.00 |
| IRadimed (IRMD) | United States | $0.841B | 40.85 |
| SiBone (SIBN) | United States | $0.741B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.713B | 0.00 |
| AxoGen (AXGN) | United States | $0.577B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.508B | 7.90 |
| OrthoPediatrics (KIDS) | United States | $0.495B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.475B | 10.23 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.422B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.412B | 9.58 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.369B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.348B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.336B | 0.00 |
| RxSight (RXST) | United States | $0.317B | 0.00 |
| NeuroPace (NPCE) | United States | $0.295B | 0.00 |
| Neuronetics (STIM) | United States | $0.292B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.280B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.253B | 0.00 |
| 908 Devices (MASS) | United States | $0.230B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.224B | 13.59 |
| CVRx (CVRX) | United States | $0.197B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.192B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.176B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.167B | 0.00 |
| LENSAR (LNSR) | United States | $0.149B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.145B | 0.00 |
| Accuray (ARAY) | United States | $0.144B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.117B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.111B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.108B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.092B | 55.80 |
| EnVVeno Medical (NVNO) | United States | $0.085B | 0.00 |
| InspireMD (NSPR) | United States | $0.082B | 0.00 |
| Hyperfine (HYPR) | United States | $0.080B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.055B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.051B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.050B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.049B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.044B | 0.00 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| DarioHealth (DRIO) | United States | $0.024B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.013B | 0.00 | |
| Tenon Medical (TNON) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.007B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.006B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 14.36 |